Interactive effects of tamoxifen and oestrogen upon the nigrostriatal dopaminergic system: Long-term treatments

Journal of Neuroendocrinology

Volumn 11, Issue 10, 1999, Pages 801-803

  McDermott, J L ^a,b   Anderson, L I ^b   Dluzen, D E ^b  

^a Edwin Shaw   (United States)

^b Northeastern Ohio Medical University   (United States)

Author keywords

Amphetamine; Anti oestrogens; Catecholamines; Ovarian steroids; Striatum

Indexed keywords

AMPHETAMINE; DOPAMINE; ESTRADIOL; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG MECHANISM; FEMALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANIMALS; CORPUS STRIATUM; CULTURE TECHNIQUES; DOPAMINE; DRUG INTERACTIONS; ESTRADIOL; FEMALE; ORGAN SIZE; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN; TIME; UTERUS;

EID: 0032848953     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1999.00395.x     Document Type: Article

References (21)

1. Cancer Research Campaign Breast Cancer Trials Group. The effect of adjuvant tamoxifen: The latest results from the cancer research campaign adjuvant breast trial. Eur J Cancer 1992; 28A: 904-907.
2. Foudraine NA, Verhoef LCG, Burghouts JTM. Tamoxifen as sole therapy for primary breast cancer in the elderly patient. Eur J Cancer 1992; 28A: 900-903.
3. Curik J, Allen D, Baum M, Barrett J, Clark G, Kakkan V, Melissari E, Moniz C, Moore J, Parsons V, Pemberton K, Pitt P, Richmond W, Houghton J, Riley D. Long term effects of tamoxifen. Eur J Cancer 1993; 29A: 15-21.
4. Powles TJ, Hardy JR, Ashley SE, Farrington GM, Cosgrove D, Davey JB, Bowsett M, McKinna JA, Nash AG, Sinnett HD, Tillyer CR, Treleaven JG. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 1989; 60: 126-131.
5. McDermott JL, Anderson LI, Dluzen DE. Interactive effects of tamoxifen and estrogen upon the nigrostriatal dopaminergic system. Neuroendocrinology 1997; 66: 181-187.
6. Fernandez-Ruiz JJ, Amor JC, Ramos JA. Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D2-receptors. Brain Res 1989; 476: 388-395.
7. Gordon JH. Modulation of apomorphine-induced stereotypy by estrogen: time course and dose response. Brain Res Bull 1980; 5: 679-682.
8. Gordon JH, Perry KO. Pre-and post-synaptic neurochemical alterations following estrogen-induced striatal dopamine hypo-and hypersensitivity. Brain Res Bull 1983; 10: 425-428.
9. Hruska RE. Elevation of striatal dopamine receptors by estrogen: dose and time studies. J Neurochem 1986; 47: 1908-1915.
10. Disshon KA, Dluzen DE. Estrogen reduces MPP+ evoked striatal dopamine release in female, but not male rats. Soc Neurosci Abstract 1998; 24: 356.
11. Ramirez VD, Kim K, Dluzen DE. Progesterone action on the LHRH and the nigrostriatal dopamine neuronal systems: in vitro and in vivo studies. Rec Prog Horm Res 1985; 41: 421-472.
12. Baksi SN, Hughes MJ, Light KE. Alterations of dopamine metabolism in different brain regions of the rabbit by estradiol and tamoxifen. Neuroscience 1985; 14: 1053-1059.
13. Hiemke C, Ghraf R. Interaction of non-steroidal anti-estrogens with dopamine binding. J Steroid Biochem 1984; 21: 663-667.
14. Toney TW, Katzenellebogen BS. An evaluation of the interactions of antiestrogens with pituitary and striatal dopamine receptors. J Recept Res 1987; 7: 695-712.
15. McDermott JL, Liu B, Dluzen DE. Tamoxifen treatment of ovariectomized mice alters dopamine release from striatal tissue fragments superfused in vitro. Brain Res 1995; 698: 248-252.
16. McDermott JL, Anderson LI, Dluzen DE. Tamoxifen alters dopamine output through direct actions upon superfused corpus striatal tissue fragments. Neurochem Int 1997; 32: 299-307.
17. Etgen AE. Effects of tamoxifen, nafoxidine and Cl-628 on sexual behavior, cytoplasmic receptors and nuclear binding of estrogen. Horm Behav 1979; 13: 97-112.
18. Meisel RL, Dohanich GP, McEwen BS, Pfaff DW. Antagonism of sexual behavior in female rats by ventromedial hypothalamic implants of antiestrogen. Neuroendocrinology 1987; 45: 201-207.
19. McKenna SE, Simon NG, Cologer-Clifford A. An assessment of agonist/ antagonist effects of tamoxifen in the female mouse brain. Horm Behav 1992; 26: 536-544.
20. Wade GN, Powers JB. Tamoxifen antagonizes the effects of estradiol on energy balance and estrous behavior in Syrian hamsters. Am J Physiol 1993; 21: 663-667.
21. Chaurasia CS, Chen C-E, Rubin J, Dewey SL. Effects of tamoxifen on striatal dopamine and 5-hydroxytryptamine release in freely moving male rats: an in vivo microdialysis investigation. J Pharm Pharmacol 1998; 50: 1377-1385.